Fundz

Everest Biolabs reported raising $4.35 Million in an initial SEC Form D filing, from an offering of $5.65 Million

PRIVATEMar 11, 2026

Amount Raised

$4.35 Million

$4.35 Million sold, per SEC Form D (first sale Feb 25, 2026)

Round Type

Seed

WalthamBiotechnologyHealth CareLife Science

Who to call at Everest Biolabs, and when

A new round usually means Everest Biolabs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Everest Biolabs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Everest Biolabs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Everest Biolabs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Everest Biolabs

Location

Waltham, Massachusetts, United States

About

Everest Biolabs is a life sciences company committed to providing essential tools for extracellular vesicle (EV) and exosome research. They focus on automating EV isolation and delivering standardized analytical tools to enhance researchers' workflows. Their innovative products aim to simplify and scale the research process, enabling scientists to focus on advancing clinical applications. With a mission to unlock the potential of EVs in clinical settings, Everest Biolabs upholds a strong commitment to innovation and scientific integrity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Everest Biolabs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsTal G., Co-Founder and Head of Research hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Everest Biolabs's next move

See what Strategic adds

Everest Biolabs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.